Evidence map›Paper›PMID 38664548›Full record

ArticleClinical and translational medicine2024

Baseline CD4

Chiara Massa, Thomas Karn, Karsten Weber, Andreas Schneeweiss, Claus Hanusch, Jens Uwe Blohmer, Dirk-Michael Zahm, Christian Jackisch, Marion van Mackelenbergh, Jörg Thomalla and 12 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and translational medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. γδ T cells and cancer.The Journal of clinical investigation · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Chiara MassaInstitute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle, Germany.ORCID 0000-0002-5544-4958
Thomas KarnDepartment of Obstetrics and Gynecology, Goethe University, Frankfurt, Germany.
Karsten WeberGerman Breast Group, GBG Forschungs GmbH, Neu-Isenburg, Germany.
Andreas SchneeweissNationales Centrum für Tumorerkrankungen, Universitätsklinikum und Deutsches Krebsforschungszentrum, Heidelberg, Germany.
Claus HanuschRotkreuzklinikum München, München, Germany.
Jens Uwe BlohmerGynäkologie mit Brustzentrum der Charite CCM, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Dirk-Michael ZahmSRH Wald-Klinikum Gera, Gera, Germany.
Christian JackischDepartment of Obstetrics and Gynecology, Sana Klinikum Offenbach, Offenbach, Germany.
Marion van MackelenberghKlinik für Gynäkologie und Geburtshilfe, Universitätsklinikum Schleswig-Holstein, Kiel, Germany.
Jörg ThomallaPraxis für Hämatologie und Onkologie, Koblenz, Germany.
Frederik MarméUniversitätsfrauenklinik, Medizinische Fakultät Mannheim der Universität Heidelberg, Heidelberg, Germany.
Jens HuoberBreast Cancer, Cantonal Hospital St.Gallen, St. Gallen, Switzerland.
Volkmar MüllerDepartment of Obstetrics and Gynecology, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.
Christian SchemMammazentrum am Krankenhaus Jerusalem, Hamburg, Germany.
Anja MüllerInstitute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle, Germany.
Elmar StickelerKlinik für Gynäkologie und Geburtsmedizin, Uniklinik RWTH Aachen, Aachen, Germany.
Katharina BiehlInstitute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle, Germany.
Peter A FaschingDepartment of Obstetrics and Gynecology, Universitätsklinikum Erlangen, Erlangen, Germany.
Michael UntchDepartment of Obstetrics and Gynecology, HELIOS Klinikum Berlin Buch, Berlin, Germany.
Sibylle LoiblGerman Breast Group, GBG Forschungs GmbH, Neu-Isenburg, Germany.
Carsten DenkertInstitute of Pathology, Philipps-University Marburg and University Hospital Marburg (UKGM), Marburg, Germany.
Barbara SeligerInstitute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle, Germany.

Funding

CelgeneGerman Cancer Aid 70113311German Cancer Aid #70113450
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antibodies, MonoclonalCD4-Positive T-LymphocytesTriple Negative Breast NeoplasmsAntineoplastic Agents, ImmunologicalFemaleHumansIntraepithelial LymphocytesMiddle AgedAntibodies, MonoclonalAntineoplastic Agents, Immunologicaldurvalumab

Identifiers

PMID38664548
PMCPMC11045558

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.